Chiesi Farmaceutici S.p.A.’s Acquisition of Raxone/idebenone From Santhera Pharmaceuticals AG

Marco Zingaro
Tagged:

Schellenberg Wittmer advised Santhera Pharmaceuticals Holding AG on the operation.Schellenberg Wittmer advised Santhera Pharmaceuticals Holding AG on the sale of its Raxone®/idebenone business for all indications…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Marco Zingaro

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here